U.S. Neurovascular Devices Market Size & Outlook
Related Markets
U.S. neurovascular devices market highlights
- The U.S. neurovascular devices market generated a revenue of USD 1,773.3 million in 2024 and is expected to reach USD 2,667.4 million by 2033.
- The U.S. market is expected to grow at a CAGR of 4.6% from 2025 to 2033.
- In terms of segment, cerebral embolization and aneurysm coiling devices was the largest revenue generating device type in 2024.
- Neurothrombectomy Devices is the most lucrative device type segment registering the fastest growth during the forecast period.
Neurovascular devices market data book summary
| Market revenue in 2024 | USD 1,773.3 million |
| Market revenue in 2033 | USD 2,667.4 million |
| Growth rate | 4.6% (CAGR from 2025 to 2033) |
| Largest segment | Cerebral embolization and aneurysm coiling devices |
| Fastest growing segment | Neurothrombectomy Devices |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Cerebral Embolization and Aneurysm Coiling Devices, Cerebral Angioplasty and Stenting Systems, Neurothrombectomy Devices, Support Devices, Trans Radial Access Devices |
| Key market players worldwide | Medtronic PLC, Johnson & Johnson, Penumbra Inc, MicroPort Scientific Corp, Stryker Corp, Terumo Corp, Integra Lifesciences Holdings Corp, Acandis GmbH, Spiegelberg, Zylox |
Other key industry trends
- In terms of revenue, U.S. accounted for 24.2% of the global neurovascular devices market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In North America, U.S. neurovascular devices market is projected to lead the regional market in terms of revenue in 2033.
- Canada is the fastest growing regional market in North America and is projected to reach USD 397.2 million by 2033.
Cerebral embolization and aneurysm coiling devices was the largest segment with a revenue share of 37.06% in 2024. Horizon Databook has segmented the U.S. neurovascular devices market based on cerebral embolization and aneurysm coiling devices, cerebral angioplasty and stenting systems, neurothrombectomy devices, support devices, trans radial access devices covering the revenue growth of each sub-segment from 2021 to 2033.
An increasing number of initiatives being undertaken by various organizations is expected to fuel neurovascular devices market growth in the U.S. For instance, the Bee Foundation (TBF), a nonprofit organization, is focused on spreading awareness and reducing the number of deaths due to cerebral aneurysm through innovative research.
The TBF invites proposals for brain aneurysm research grant, which is likely to help the organization achieve its aim of reducing mortality due to brain aneurysms. These factors are expected to boost the market during the forecast period.
Furthermore, according to the Brain Aneurysm Foundation, more than 6.5 million people in the U.S. have an unruptured brain aneurysm. In addition, approximately, 30,000 people suffer an intracranial aneurysm rupture annually.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Neurovascular Devices Market Scope
Neurovascular Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Zylox | View profile | 501-1000 | Hangzhou, Zhejiang, China, Asia | http://www.zyloxmedical.com/ |
| Acandis GmbH | View profile | 251-500 | Pforzheim, Baden-Wurttemberg, Germany, Europe | https://www.acandis.com/start-1-en |
| Spiegelberg | View profile | 11-50 | Hamburg, Hamburg, Germany, Europe | https://www.spiegelberg.de/en/ |
| Penumbra Inc | View profile | 4200 | One Penumbra Place, Alameda, CA, United States, 94502 | https://www.penumbrainc.com |
| MicroPort Scientific Corp | View profile | 8230 | 1601 Zhangdong Road, Zhangjiang Hi-Tech Park, Shanghai, China, People's Republic of, 201203 | https://www.microport.com |
| Terumo Corp | View profile | 30207 | 2-44-1 Hatagaya, Shibuya-ku, Tokyo, Japan, 151-0072 | https://www.terumo.com |
| Integra Lifesciences Holdings Corp | View profile | 3946 | 1100 Campus Road, Princeton, NJ, United States, 08540 | https://www.integralife.com |
| Stryker Corp | View profile | 52000 | 1941 Stryker Way, Portage, MI, United States, 49002 | https://www.stryker.com |
| Medtronic PLC | View profile | 95000 | Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 | https://www.medtronic.com |
| Johnson & Johnson | View profile | 134400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | https://www.jnj.com |
U.S. neurovascular devices market size, by device type, 2021-2033 (US$M)
U.S. Neurovascular Devices Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
